Randomized controlled trial of interferon-beta-1a in secondary progressive MS: Clinical results

Neurology

Volumn 56, Issue 11, 2001, Pages 1496-1504

  Francis, G ^a  

^a MS CDU   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SEX DIFFERENCE;

EID: 0035849496     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.11.1496     Document Type: Article

References (21)

1. Defining the clinical course of multiple sclerosis: Results of an international survey
2. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
3. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis
4. Randomized double-blind placebo-controlled study of interferon-1a in relapsing/remitting multiple sclerosis
5. Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis
6. Evidence of interferon B-1a dose response in relapsing-remitting MS
7. Magnetic resonance studies of intramuscular interferon α-1a for relapsing multiple sclerosis
8. Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial
9. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis
10. Chemicalpathology of acute demyelinating lesions and its correlation with disability
11. Axonal transection in the lesions of multiple sclerosis
12. Axonal pathology in multiple sclerosis: Relationship to neurologic disability
13. Interferon beta-1b in secondary progressive MS clinical and MRI results of a 3-year randomized controlled trial
14. Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results
15. Problems of experimental trials of therapy in multiple sclerosis: Report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis
16. A scaled version of the General Health Questionnaire
17. The CES-D scale: A self-report depression scale for research in the general population
18. "Summary measure" statistic for assessing the outcome of treatment trials in relapsing-remitting multiple sclerosis
19. Procedures for comparing samples with multiple endpoints